|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Risk of thromboembolic disease and oral contraceptive use. [Risque de |
| maladie thrombo-embolique et contraceptifs oraux.] |
| Contraception, Fertilite, Sexualite. 1996 May;24(5):378-83. |
| Four studies recently showed an increased risk of venous thromboembolic events (VTE) in current users of oral |
| contraceptives (OCs). This risk was higher in users of OCs containing third generation progestagens than in users of |
| OCs containing levonorgestrel. The excess of VTE attributable to the third generation pills should be about |
| 10/100,000 woman-years. Conversely, the risk of death due to cardiovascular disease was not significantly |
| increased in users of third generation pills. In addition, the risk of myocardial infarction associated with these latter |
| types of pill was two-fold lower than the risk associated with the pills containing levonorgestrel, and this decrease |
| was of borderline significance (p = 0.10). The results of these different studies are described and discussed in this |
| paper. (summaries in ENG, FRE) (PubHealth.info Document ID: CONT2T 2076-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Risk of thromboembolic disease and oral contraceptive |
| use. [Risque de maladie thrombo-embolique et contraceptifs oraux.]", is(are) Le MG. The source of this article is |
| "Contraception, Fertilite, Sexualite. 1996 May;24(5):378-83.". This article was published in 1996 in French |
| language(s). (PubHealth.info® Document ID: CONT2T 2076-06. All rights reserved with PubHealth.info) PIN: 7076 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |